INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
(NASDAQ: INMB) Delayed: 1.42 -0.01 (0.7%)
Previous Close $1.43    52 Week High $ 
Open $1.39    52 Week Low $ 
Day High $1.50    P/E N/A 
Day Low $1.39    EPS $ 
Volume 432,229